Pro Medicus Limited(PMCUF)
USD --+0.00%
Reward75High
Risk18Low
📊75%Data
Strong 98% profit margin · Revenue growing 28% YoY
PMCUF
+0.0 · +0.00%
USD · PINK
Pro Medicus Limited | Healthcare
Quality Compounder
Market Cap:8.80Bn
ℹ️
Reward Rating
75
High
Top 10% (model universe)
75% data coverage
ℹ️
Risk Rating
18
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on PMCUF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Pro Medicus Limited?

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe.

PMCUF · Verdict

Strong reward · low risk

PMCUF stands out on balance sheet and profitability, but watch the valuation signal.

Based on 88% data coverage

PMCUF · Verdict

What’s working & what to watch

Strengths 5

  • Balance sheet100/100

    Current ratio 6.49

  • Profitability97/100

    54% net margin · 77% ROE

  • Growth96/100

    Rev +31.6% CAGR · earnings +37.4%

  • Cash flow82/100

    49% free-cash-flow margin

  • Volatility65/100

    Above average

Watchouts 1

  • Valuation28/100

    P/E 84.7×

Model-based scoring. For information only — not financial advice.

What is Pro Medicus Limited?

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 8.80B, and a P/E ratio of 50.3x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (75)

The scoring profile indicates a strong reward potential, driven primarily by profitability and growth. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap8.80B
P/E Ratio50.2563
Dividend Yield0.77%
52 Week High217.0251
52 Week Low74.2188
Last AnnualJune
IPO DateN/A
IncorporatedUSA
Shares Outstanding104M
No. of Employees132
IndustryHealth Information Services
ExchangePINK
Beta0.604
CurrencyUSD · Reports in AUD